This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Communities and Collections
Usage
- 199 views
- 265 downloads
Melatonin for cognitive impairment (Protocol)
-
- Author(s) / Creator(s)
-
This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is a systematic review of evidence relating to clinical efficacy and safety of melatonin in treatment of manifestations of dementia or cognitive impairment (CI).
-
- Date created
- 2002
-
- Subjects / Keywords
-
- Type of Item
- Article (Published)
-
- License
- © 2002 The Cochrane Collaboration for John Wiley & Sons, Ltd. This version of this article is open access and can be downloaded and shared. The original author(s) and source must be cited.